Ligand validation:6XS3

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6XS3_NAG_B_305	21%	80%	0.147	0.754	0.37	0.48	-	-	0	0	100%	1
6XS3_NAG_C_304	6%	86%	0.158	0.594	0.3	0.42	-	-	0	0	93%	1
6XS3_NAG_A_303	4%	44%	0.168	0.539	1.28	0.89	1	1	0	0	100%	1
6XS3_NAG_E_303	4%	89%	0.169	0.552	0.19	0.45	-	-	0	0	93%	1
6XS3_NAG_D_303	4%	82%	0.178	0.554	0.17	0.62	-	-	0	0	93%	1
6XS3_NAG_F_303	3%	77%	0.198	0.525	0.35	0.57	-	-	3	0	93%	1
6XOK_NAG_A_301	89%	72%	0.087	0.967	0.48	0.59	-	-	0	0	100%	1
5AP9_NAG_A_300	89%	40%	0.073	0.95	1.08	1.27	1	2	0	0	100%	1
6O8V_NAG_A_301	88%	71%	0.085	0.961	0.48	0.62	-	-	0	0	100%	1
6XRV_NAG_B_305	87%	76%	0.07	0.942	0.37	0.56	-	-	0	0	100%	1
7APP_NAG_B_301	74%	38%	0.12	0.95	0.73	1.67	1	1	1	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.